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SUMMARY
Application of the bacterial CRISPR/Cas systems to eukaryotes is revolutionizing biology. Cas9 and Cas12
(previously called Cpf1) are widely used as DNA nucleases for inducing site-specific DNA breaks for different
kinds of genome engineering applications, and in their mutated forms as DNA-binding proteins to modify
gene expression. Moreover, histone modifications, as well as cytosine methylation or base editing, were
achieved with these systems in plants. Recently, with the discovery of the nuclease Cas13a (previously
called C2c2), molecular biologists have obtained a system that enables sequence-specific cleavage of single-
stranded RNA molecules. The latest experiments with this and also the alternative Cas13b system demon-
strate that these proteins can be used in a similar manner in eukaryotes for RNA manipulation as Cas9 and
Cas12 for DNA manipulations. The first application of Cas13a for post-transcriptional regulation of gene
expression in plants has been reported. Recent results show that the system is also applicable for combat-
ing viral infection in plants. As single-stranded RNA viruses are by far the most abundant class of viruses in
plants, the application of this system is of special promise for crops. More interesting applications are immi-
nent for plant biologists, with nuclease dead versions of Cas13 enabling the ability to visualize RNA mole-
cules in vivo, as well as to edit different kinds of RNA molecules at specific bases by deamination or to
modify them by conjugation. Moreover, by combining DNA- and RNA-directed systems, the most complex
of changes in plant metabolism might be achievable.
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INTRODUCTION
The recent emergence of the CRISPR/Cas (clustered
regularly interspaced short palindromic repeats and
CRISPR-associated) system as a biotechnological tool has
revolutionized molecular biology (Jinek et al., 2012). It
enables precise and efficient induction of DNA double-
strand breaks (DSB) at any site in the genome. Even
though targeted DSB induction was possible with different
technologies before (Kim et al., 1996; Boch et al., 2009;
Voytas, 2013), the CRISPR/Cas system was a breakthrough:
its advantage resides in RNA-based sequence specificity,
enabling a very simple, fast and reliable design process.
After DSB induction, the cell’s inherent DSB repair mecha-
nisms can be harnessed for genome-editing purposes,
which was demonstrated over 20 years ago (Puchta et al.,
1996; Salomon and Puchta, 1998).
The natural CRISPR/Cas systems are adaptive immune
systems of prokaryotes and offer enormous diversity.
Current classification differentiates two classes, six types
and many more subtypes of CRISPR (Koonin et al., 2017;
Shmakov et al., 2017). The defining feature differentiating
the two classes is the nature of the effector cleaving the
target sequence. Class 1 systems (including type I, III and
IV) employ several Cas proteins and crRNA to form multi-
subunit effector complexes, whereas Class 2 systems
(including type II, V and VI) employ a single, large, multi-
domain protein. Class 1 systems are the most abundant
CRISPR/Cas systems found in both bacteria and Archaea.
Class 2 systems are much less common and largely
restricted to bacteria (Burstein et al., 2017). The Class 2
type II system of Streptococcus pyogenes was the first to
be transformed into a genome engineering tool. In the nat-
ural system, a complex of the large multi-domain protein
Cas9 and two short RNAs, tracrRNA and crRNA, is able to
cleave foreign plasmid or viral DNA entering the cell.
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Cleavage is dependent on the presence of a short
sequence motif next to the target sequence termed proto-
spacer adjacent motif (PAM). Cas9 contains two nuclease
domains, RuvC and HNH, each cleaving one strand 3 bp
upstream of the PAM (Jinek et al., 2012).
In its simplest form, the CRISPR/Cas system can be used
for sequence-specific mutagenesis, which is now a routine
procedure. This is mainly used to disrupt genes in order to
analyse their function, but can also be used to improve
traits in crops (see Pacher and Puchta, 2017 and Scheben
et al., 2017 for an overview of modified traits). However,
the CRISPR/Cas system is a much more versatile tool
(Puchta, 2017). Cas9 can be transformed into a DNA-bind-
ing protein by mutating its two nuclease domains. This
way, its DNA cleavage activity is deactivated but its DNA-
binding potential remains intact. By fusing this nuclease
‘dead’ Cas9 (dCas9) directly or indirectly to an effector
domain, it can then be used to guide diverse enzymatic
functions to any specific site in the genome (Gilbert et al.,
2013; Konermann et al., 2015). This enables the use of
CRISPR/Cas for many diverse site-specific manipulations,
such as regulation of gene expression (Piatek et al., 2015;
Tang et al., 2017), epigenetic modifications (Hilton et al.,
2015; Thakore et al., 2015), imaging of genomic loci in live
cells (Dreissig et al., 2017), or base editing without DSB
induction enabled by fusion of deaminases (Komor et al.,
2016; Zong et al., 2017).
Due to their considerable diversity, natural CRISPR/Cas
systems are a very rich, and up to now still largely
untapped, resource for further biotechnological tools.
Using data-mining of microbial sequence databases
along with bioinformatic prediction approaches, more
and more CRISPR/Cas systems beyond CRISPR/Cas9 of S.
pyogenes are being identified (Makarova et al., 2015;
Shmakov et al., 2017). However, in order to become a
useful genome engineering tool, a newly identified
CRISPR system must exhibit activity in eukaryotic cells, a
property that is confined to only a small subset of the
abundant diversity. Still, extensive screening efforts were
fruitful in yielding not only further Class 2 type II sys-
tems, whose defining hallmark protein is Cas9, like those
from Streptococcus thermophilus (Esvelt et al., 2013) or
Staphylococcus aureus (Ran et al., 2015), but also sys-
tems from completely different Class 2 types. The first
Class 2 effector bioinformatically identified other than
Cas9 was Cas12 (Schunder et al., 2013) (then known as
Cpf1), which was assigned to Class 2 type V (Makarova
et al., 2015). Zetsche et al. (2015) then screened various
orthologues of Cas12a, and identified two showing high
activity in eukaryotic cells. Due to its unique properties,
like requiring completely different PAMs and generating
staggered breaks as opposed to the blunt breaks induced
by Cas9, this was an extremely useful expansion of the
genome engineering toolbox.
Bullet Point Summary
• Cas13 is a newly identified CRISPR effector that
specifically cleaves single-stranded RNA in eukaryotic
cells, opening up a wide range of new possibilities.
• The RNA cleavage ability can be used for downregu-
lation of specific transcripts with improved specificity
over RNAi.
• A first report demonstrated the successful use of
Cas13 to combat RNA viruses in plants.
• Analogous to Cas9, Cas13 can be converted into a
RNA-binding platform by inactivation of its nuclease
domain.
• This enables diverse RNA manipulations, from base
editing to base modification to visualization.
A NEW PLAYER THAT TAKES US TO THE RNA LEVEL:
CAS13
More recently, Shmakov et al. (2015) bioinformatically pre-
dicted three novel Class 2 effectors, termed Class 2 candi-
date1 (C2c1), C2c2 and C2c3. Whereas C2c1 and C2c3 show
similarity to Cas12, C2c2 is utterly unrelated. Due to its
unique features, this system, now known as CRISPR/
Cas13a, was assigned to a completely new type, Class 2
type VI. The presence of HEPN (higher eukaryotes and
prokaryotes nucleotide-binding) domains, which are exclu-
sively associated with RNase activity, suggested that
Cas13, as opposed to all other functionally characterized
CRISPR systems, acts exclusively on RNA. This auspicious
hypothesis could later be confirmed (Abudayyeh et al.,
2016): Cas13 cleaves single-stranded, but not double-
stranded, RNA (Figure 1). Intriguingly, after activation by
the target RNA, other RNAs in the solution were cleaved as
well in an unspecific manner. This suggests that in the nat-
ural system Cas13 elicits programmed cell death or dor-
mancy. The same group also identified a Cas13 orthologue
with high activity in eukaryotic cells (Abudayyeh et al.,
2017; Cox et al., 2017). Most importantly, the unspecific
RNA degradation observed in vitro and in prokaryotic cells
was absent in eukaryotic cells, enabling highly specific
RNA targeting in higher organisms. These findings opened
up a wide range of new possibilities by targeted RNA
manipulation.
Quickly after the first report on the RNA targeting capa-
bility of Cas13, its structure was analysed in detail (Liu
et al., 2017a). Similar to other Class 2 effectors, Cas13
adopts a bilobed architecture consisting of a recognition
and a nuclease lobe, but the domains involved are utterly
distinct and unrelated to other Class 2 effectors. Just like
Cas12, Cas13 proteins exhibit the ability to process pre-
crRNA on their own without the involvement of tracrRNA.
The activity responsible for crRNA maturation is distinct
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from the target RNA cleavage activity and is mediated by
another domain, the Helical1 domain. Similar to type V
systems (containing Cas12), the crRNA in Cas13-contain-
ing systems contains a single stem loop in the direct
repeat (DR). Cas13 undergoes substantial conformational
change not only upon binding of crRNA but also upon
target RNA binding. The latter leads to activation of the
HEPN catalytic site, which is formed by two very struc-
turally distinct HEPN domains, HEPN1 and HEPN2. In con-
trast to the catalytic sites in Cas9 and Cas12, which are
located deep inside the protein, the HEPN catalytic site of
activated Cas13a is located on the outer surface, leading
to cleavage of the target RNA outside of the binding
region. Intriguingly, it also causes unspecific cleavage of
other RNAs in the surrounding solution (East-Seletsky
et al., 2016; Liu et al., 2017a,b).
USING CAS13 FOR TARGETED CLEAVAGE OF CELLULAR
RNA
In its simplest form, Cas13 can be used for targeted RNA
cleavage, for example for downregulation of a specific
transcript (Figure 2a). Abudayyeh et al. (2017) identified
Cas13a from Leptotrichia wadei as the most active Cas13a
orthologue for targeted RNA knockdown in human cells.
Although some Cas13a orthologues require a protospacer
flanking site (PFS) analogous to the PAM, there was no
such restriction for LwaCas13a. However, its high activity
was dependent on a stabilization domain (msfGFP). Con-
cerning cellular localization, fusion of a nuclear localization
signal yielded higher efficiencies than nuclear export sig-
nals. The level of RNA knockdown was comparable to
RNAi but, in terms of specificity, the Cas13a system was
clearly superior. Single and double mismatch analysis
revealed the presence of a mismatch-sensitive ‘seed
region’ in the centre of the spacer, which can be explained
by the structural finding that the central part of the spacer
is exposed to the solvent and recognizes the target RNA
first (Liu et al., 2017a). Strikingly, transcriptome-wide
mRNA sequencing detected hundreds of significant off-tar-
gets for RNAi approaches, but no differentially expressed
genes other than the target gene for LwaCas13a-mediated
RNA knockdown. This suggested a lack of collateral RNA
degradation activity as described for Leptotrichia shahii
Cas13a (Abudayyeh et al., 2016), at least in eukaryotic cells.
Figure 1. Schematic comparison of the enzyme
complexes (a) Cas9 and (b) Cas13a.
The bars show the domain organization. The drawn
sizes of the domains correspond to their true size.
Red asterisks indicate catalytic sites for target DNA/
RNA cleavage. The green asterisk indicates the cat-
alytic site for pre-crRNA processing. Dark red trian-
gles indicate cleavage of the target DNA/RNA. BH,
bridge helix; PI, PAM interacting domain; NTD, N-
terminal domain.
© 2018 The Authors
The Plant Journal © 2018 John Wiley & Sons Ltd, The Plant Journal, (2018), 94, 767–775
Cas13, the revolution reaches the RNA world 769
By the same group, the functionality of LwaCas13a-
mediated RNA knockdown was also confirmed for plants:
three different genes were targeted in rice protoplasts, with
most guides exceeding 50% knockdown at only 48 h after
transformation. This demonstrates that Cas13 can rapidly
diminish the cytoplasmic RNA pool in plants. In addition, it
indicates a broad range of editable organisms beyond
human cells for LwaCas13a. Furthermore, Abudayyeh et al.
(2017) could successfully harness the crRNA maturation
activity of LwaCas13a for multiplexing approaches, as was
demonstrated for Cas12 before (Zetsche et al., 2017).
Using a computational sequence data-mining approach
with altered characteristics, another Class 2 effector con-
taining HEPN domains and acting on RNA was identified.
Due to its similarity to Cas13a, it was termed Cas13b (pre-
viously C2c6), and assigned to Class 2 subtype VIB (Smar-
gon et al., 2017). Interestingly, these CRISPR systems lack
the otherwise ubiquitous Cas1 and Cas2 proteins. Instead
they contain two previously uncharacterized associated
proteins, Csx27 and Csx28, with Csx27 repressing and
Csx28 enhancing Cas13b-mediated RNA cleavage. A large
screen for RNA-targeting activity in eukaryotic cells yielded
a Cas13b orthologue, from Prevotella sp. P5-125, showing
consistently higher efficiencies than LwaCas13a (Cox et al.,
2017). In addition, its high activity was not dependent on
the msfGFP stabilization domain and, in contrast to Lwa-
Cas13a, was most efficient when combined with a nuclear
export signal. Just like LwaCas13a, PspCas13b lacked col-
lateral RNA degradation in eukaryotic cells, did not show
any PFS requirements and showed similar specificity,
including the mismatch-sensitive central seed region. Fur-
thermore, PspCas13b is amenable to multiplexing in the
same way as Cas13a due to an inherent crRNA processing
activity. This makes PspCas13b the first choice at the
moment for targeted RNA cleavage. It would be interesting
to test if this applies for plant cells as well.
The RNA-cleaving ability of Cas13 further opens up new
opportunities for advances in basic research relating to the
Figure 2. Applications of Cas13 for plant biology.
Active Cas 13 can be used for specific cleavage of target RNAs for downregulation of expression (a) and for defence against plant RNA viruses (b). When the
RNA cleavage site is inactivated, dCas13 can be used to direct various effectors to specific RNAs (c) or to visualize specific RNAs in live cells (d).
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functions of non-coding RNAs (ncRNAs). In theory, all
ncRNAs exceeding a certain size should be amenable to
Cas13-mediated cleavage. In plants, this mainly applies to
long non-coding RNAs (lncRNAs), which now include a cat-
egory referred to as intermediate sized non-coding RNAs
(im-ncRNAs), arbitrarily defined as 50–300 nt long (Wang
and Chekanova, 2017). Computational approaches identi-
fied over 6000 lncRNAs from Arabidopsis transcriptomic
data sets, with mostly tissue-specific or stress-induced
expression profiles (Liu et al., 2015). lncRNAs are involved
in a wide range of processes in plants: they can regulate
gene expression at all stages, function as scaffolds for the
assembly of protein complexes, guide protein transloca-
tion, influence alternative splicing and modulate chromatin
loop dynamics (for review, see Liu et al., 2015; Wang and
Chekanova, 2017). However, many more functions of plant
lncRNAs and the related mechanisms remain to be discov-
ered, but functional studies on lncRNAs are hampered by a
lack of mutants (Liu et al., 2015). In addition to creating
these mutants on the DNA-level using Cas9 or Cas12,
Cas13 now enables to directly cleave these RNAs in vivo,
providing greater flexibility in experimental manipulations.
For example, using Cas13 it should now be possible to
knockdown a specific RNA in the tissue of interest using a
tissue-specific promoter, in cases where complete knock-
out mutants are lethal. Furthermore, different knockdown
intensities can be analysed in addition to complete knock-
out. Opposed to RNAi, Cas13 offers the advantage that it is
not limited to cytoplasmic transcripts, but non-coding
nuclear transcripts can also be targeted by fusing a NLS to
Cas13.
Another possible application of Cas13 for basic
research is the functional analysis of the tRNA cleavage
mechanism, which involves the release of ribonucleases
cleaving in the anticodon loop of mature tRNAs upon
stress signals. For example, Arabidopsis seedlings sub-
jected to oxidative stress via H2O2 treatment showed a
strong increase in cleaved tRNA fragments (Thompson
et al., 2008). The cleavage fragments then inhibit transla-
tion beyond the reduced availability of functional tRNAs,
but the exact mechanism of inhibition is not yet eluci-
dated. Cas13 could now enable artificial cleavage of
tRNAs, although there are probably two challenges. First,
it is unclear whether the modified nucleotides present in
mature tRNA interfere with Cas13 cleavage. The second
challenge will be to direct Cas13-mediated cleavage to
the correct nucleotides. The tRNA cleavage of the
endogenous RNases occurs at varying positions in the
anticodon loop (Thompson et al., 2008). Cas13-mediated
cleavage was found to occur mostly at Uracil residues at
the base of loop structures (Abudayyeh et al., 2016), so
the base of the tRNA anticodon loop should be tar-
getable by Cas13. Thus, due to Cas13 the analysis of the
tRNA cleavage mechanism might be no longer restricted
to observation, but become more accessible for experi-
mental manipulation to dissect its functions.
USING CAS13 FOR COMBATING RNA VIRUSES
It was already shown that the DNA-targeting ability of
CRISPR/Cas9 can be used for defence against plant DNA
viruses (Ali et al., 2015). Yet, RNA viruses are the most
common form of plant viruses, and even many plant DNA
viruses contain an RNA intermediate at some stage of their
life cycle (Roossinck, 2003; Nicaise, 2014). The yield losses
that can be ascribed to plant viruses were estimated to be
more than $30 billion annually (Sastry and Zitter, 2014).
Worse, viral epidemics are often associated with famine
events, for example in the case of Cassava, which consti-
tutes the staple crop for more than 500 million people
(Nicaise, 2014). In a pioneering study, Aman et al. (2018)
demonstrated that the RNA-targeting ability of Cas13 can
be used to combat RNA viruses (Figure 2b). They
employed LshCas13a for interference against Turnip
Mosaic Virus (TuMV), a Potyvirus, in Nicotiana benthami-
ana. They infiltrated leaves with mixed agrobacterium cul-
tures carrying GFP expressing TuMV as well as LshCas13a
containing a C-terminal NLS and different crRNAs targeting
different parts of the viral genome. Seven days post-infil-
tration, about 50% reduction in GFP signal was observed
for two of the tested crRNAs targets, but only a minor
reduction in the case of the other two targets. These
results could be confirmed in transgenic N. benthamiana
lines stably expressing LshCas13a infiltrated with TuMV
and crRNAs.
The off-target issue was not systematically addressed
in this study, but no adverse effect on plant vitality was
reported, suggesting that at least no collateral RNA
degradation occurred in plant cells, which was reported
for LshCas13a in prokaryotic cells and under in vitro con-
ditions (Abudayyeh et al., 2016; Gootenberg et al., 2017).
Although the efficiency of RNA virus interference was
only modest in this study, it should be noted that it was
achieved using the first characterized Cas13 variant. As
mentioned above, more efficient Cas13 variants are avail-
able by now, which should translate into stronger virus
interference. Besides, not all targets on the virus genome
were effective, suggesting that target RNA accessibility
impacts Cas13a activity, a limitation noted before (Abu-
dayyeh et al., 2017). Accordingly, it is advisable to
always test multiple target sequences for each RNA
targeted.
In addition to direct interference, there is another way in
which Cas13 could be harnessed as a weapon against viral
diseases. It relies on the ‘collateral’ RNA cleavage upon
activation by a target RNA observed in vitro and in
prokaryotic cells. This obviously prevents specific RNA
cleavage under these conditions. However, the conforma-
tional change leading to activation of Cas13 itself remains
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specific. In an elaborate way, this property can be
exploited for highly sensitive detection of nucleic acids
in vitro, as demonstrated by Gootenberg et al. (2017). In
their technique termed SHERLOCK (Specific High-Sensitiv-
ity Enzymatic Reporter UnLOCKing), the target DNA is
amplified under isothermal conditions via recombinase
polymerase amplification, reverse transcribed into RNA
and subjected to Cas13a cleavage in the presence of a
quenched RNA reporter that releases its fluorescence sig-
nal when collaterally cleaved by Cas13a (Figure 3). A speci-
fic RNA can be detected in the same manner, simply by
reverse transcribing it into DNA before isothermal amplifi-
cation. Their system makes use of the Cas13a orthologue
from L. wadei (LwaCas13a). Remarkably, they achieved sin-
gle-molecule sensitivity and single-mismatch specificity.
Thus, SHERLOCK was able to clearly discriminate between
Zika virus (ZIKV) and the related flavivirus Dengue (DENV),
and could detect viral particles down to a concentration of
2aM.
Importantly, all SHERLOCK components including
Cas13a–crRNA complexes can be lyophilized and later
rehydrated, enabling the use of SHERLOCK in the field with
paper-spotting. Moreover, all components can be com-
bined in a single reaction, making the procedure simple
and fast. This combined with its high sensitivity should
enable the use of SHERLOCK for rapid detection of plant
pathogenic viruses. Early and reliable detection is a key
point for viral disease management in the fields (Boonham
et al., 2014), enabling more efficient and affordable coun-
termeasures, for example in order to minimize the spread
of the virus, infected plants need to be removed as fast as
possible (Nicaise, 2014). Due to its high mismatch-sensitiv-
ity, differentiation between highly similar viral strains
should also be possible and enable precisely adjusted
intervention.
USING CAS13 FOR PRECISE RNA MODIFICATIONS AND
VISUALIZATION
Analogous to Cas9 and Cas12, the catalytic residues in the
HEPN domains of Cas13 responsible for cleaving the target
RNA can be deactivated by point mutations, creating a cat-
alytically ‘dead’ dCas13. This way, a programmable RNA-
binding protein is obtained. Abudayyeh et al. (2017) used
dLwaCas13a fused to fluorescent proteins for specific
imaging of transcripts in live cells. However, due to high
levels of background noise from unbound protein, this
required a negative-feedback system based upon zinc fin-
ger self-targeting and KRAB domain repression. Using this
system, they were able to follow mRNA translocation into
stress granules in live cells, and the fluorescent signals
obtained correlated well with signals from fluorescent
in situ hybridization. Fluorescent imaging of specific DNA
sequences is already established in plants (Dreissig et al.,
2017). With the new Cas13 system at hand, visualizing the
dynamics of RNA in live plant cells is also within reach
now (Figure 2d).
Another new possibility enabled by Cas13 is precise
RNA base editing. It was shown before that fusion of a cyti-
dine or adenosine deaminase to deactivated or single-
strand break inducing Cas9 can efficiently generate precise
point mutations (Komor et al., 2016; Gaudelli et al., 2017)
Now, Cox et al. (2017) have shown that using Cas13b, RNA
can be edited in an analogous manner (Figure 2c). They
chose the adenosine deaminase acting on RNA 2 deami-
nase domain (ADAR2DD) containing a hyperactivating
mutation (E488Q) as an effector. This enzyme catalyses
hydrolytic deamination of adenosine to inosine, which is
functionally equivalent to guanosine in translation and
splicing. In the end, this results in targeted A to G replace-
ment on RNA. Editing efficiency was enhanced by using
longer spacers (50 nt) that contained a mismatch at the site
of the edited adenosine, with an A–C mismatch showing
by far the highest efficiency. Using this system, they
achieved editing rates robustly at or above 50% in reporter
systems. It was also possible to correct two genes related
to human diseases, AVPR2 related to X-linked Nephrogenic
diabetes insipidus and FANCC related to Fanconi anemia,
at 35% and 23% efficiencies, respectively. Concerning
specificity, it must be noted that other adenosines on the
target RNA were also edited and RNA seq analysis
revealed many other off-targets across the entire transcrip-
tome. This issue was addressed by introducing point
Figure 3. Detection of specific nucleic acids using the SHERLOCK method.
After isothermal amplification and reverse transcription, the target nucleic
acid leads to activation of Cas13, which then cleaves the reporter. The fluo-
rescence of the released reporter can be detected.
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mutations into the ADAR2dd domain destabilizing unspeci-
fic RNA binding, which increased specificity dramatically,
with only 20 instead of 18.385 off-targets, at only slightly
decreased target editing rate. Concerning the off-targets on
the target RNA, the exact target adenosine can be strongly
favoured, as mentioned above, by placing a cytidine across
of the target adenosine, creating an A-C mismatch that
strongly promotes ADAR editing activity. It should be
noted that compared with DNA base editing, RNA base
editing is not stable but more easily reversible, allowing a
delicate temporal control over the editing process (Cox
et al., 2017). In addition, DNA editing affects all transcripts,
whereas in the case of RNA editing both edited and non-
edited transcripts can be present at the same time, which
should also enable a certain dosage control.
Specific RNA manipulations are by no means limited
to deaminase domains, but many other effector fusions
can be envisaged (Figure 2c). Translational enhancers or
repressors could be fused to dCas13 in order to regulate
translation of specific mRNAs. dCas13 could also be
combined with a trafficking agent. This way, targeted
RNAs are translocated to programmed cellular locations.
Another valuable application for research purposes could
be to use dCas13 to identify proteins bound to
specific RNAs. By fusing dCas13 to an affinity tag for
protein purification, proteins bound to the targeted RNA
can be co-precipitated and further analysed (Mahas
et al., 2017).
An interesting target for Cas13-mediated RNA editing
in plants for the purpose of basic research is tRNA. In
fact, tRNAs contain the highest density and diversity of
post-transcriptional modifications among all RNAs: there
are 112 known different modifications found across all
types of RNAs, 93 of which have been found in tRNAs
(Lorenz et al., 2017). However, the exact mechanisms as
to how tRNA modifications can regulate translation
remain unknown for most cases. The ability of Cas13 to
bring modifying effectors to specific tRNAs should now
enable targeted manipulation of tRNA modifications. This
could help to gain a better understanding of the complex
interplay between tRNA modifications and translational
regulation.
CONCLUSIONS
Taken together, the results from the studies mentioned
above demonstrate that CRISPR/Cas13 is a robust, precise
and versatile RNA-targeting system, opening up new
research horizons. Compared with previous technologies
for RNA manipulation, CRISPR/Cas13 offers several advan-
tages. Its modular composition consisting of a single pro-
tein effector module and an RNA guide module enables
not only a simple and fast design, but also large scalability
by the generation of whole libraries of different guide
RNAs. The ability to generate Cas13 mutant versions that
function as programmable RNA-binding proteins allows
for the first time to efficiently target many different effec-
tors to specific RNAs to induce subtle manipulations. Due
to the inherent crRNA biogenesis capability of Cas13, mul-
tiple RNAs can be targeted simultaneously. Compared with
RNAi, CRISPR/Cas13-mediated manipulations are not
restricted to targeting cytoplasmic transcripts, but non-cod-
ing nuclear transcripts and pre-mRNA can also be targeted
by simply adding a nuclear localization signal. Compared
with transcriptional regulation on the DNA level, which
affects all splicing isoforms in the same way, CRISPR/
Cas13 facilitates targeting of specific isoforms. This could
be helpful by eliminating aberrant or pathogenic splicing
isoforms without affecting wild-type transcripts (Mahas
et al., 2017). In addition, Cas13 enables a temporally much
faster downregulation of gene expression by directly cut-
ting away the cytoplasmic mRNA pool, whereas regulation
on the DNA level only prevents further mRNA production,
relying on the natural degradation rate of the mRNAs
present.
As suggested (Puchta, 2016) and recently demonstrated
for Cas9 orthologues (Dreissig et al., 2017; Wolter et al.,
2018), the simultaneous application of multiple editing sys-
tems in the same cell offers promising new options. Analo-
gously, the availability of several functional Cas13 variants
enables the employment of different RNA manipulations at
the same time by fusing different effectors to each variant.
DNA and RNA editing systems could also be combined.
This way, some genes can be knocked out while simultane-
ously others are knocked down by targeting their mRNAs.
Likewise, transcriptional and post-transcriptional repres-
sion of a specific gene can be combined in a single cell,
making it now possible to fine-tune expression at the DNA
and RNA levels simultaneously.
The availability of ample structural information regard-
ing Cas13 variants should enable structure guided engi-
neering of more sophisticated Cas13 systems in the
future that show enhanced properties in terms of effi-
ciency and specificity, or that are more flexible for RNA
manipulation applications. An issue that still needs to be
addressed is that the Cas13 variants available to date are
sensitive to RNA secondary structure. Thus, it would be
very promising to elucidate the underlying determinants
of this phenomenon and use this knowledge to engineer
more robust versions less sensitive to secondary struc-
ture. Regardless of the limitations of the current Cas13
systems still present, it appears that mining deeper in
the vast diversity of microbial CRISPR/Cas systems has
yet again yielded an invaluable tool for molecular biology
applications.
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Open Questions
• Can the RNA cleavage efficiency and specificity be
further improved by finding new orthologues or
structure guided engineering of new variants of exist-
ing orthologues?
• What determines the unspecific RNA cleavage
observed under some conditions? Is it always absent
in eukaryotic cells?
• How does secondary structure of the target RNA
affect cleavage, and how does this relate to the
choice of the target sequence?
• Does PspCas13b show the same high efficiency in
plants as observed in mammalian cells, and would
PspCas13b further enhance RNA virus interference in
crops?
• How flexible is the dCas13 platform for the wide
range of possible RNA modifications?
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